Gay L, Mezouar S, Cano C, Frohna P, Madakamutil L, Mege J
Front Immunol. 2022; 13:928441.
PMID: 35924233
PMC: 9340263.
DOI: 10.3389/fimmu.2022.928441.
Gay L, Mezouar S, Cano C, Foucher E, Gabriac M, Fullana M
Front Immunol. 2022; 13:915244.
PMID: 35833118
PMC: 9272908.
DOI: 10.3389/fimmu.2022.915244.
von Massow G, Oh S, Lam A, Gustafsson K
Front Immunol. 2021; 12:741218.
PMID: 34777353
PMC: 8586491.
DOI: 10.3389/fimmu.2021.741218.
Akoto C, Chan C, Ravi K, Zhang W, Vatish M, Norris S
PLoS One. 2020; 15(6):e0235162.
PMID: 32584913
PMC: 7316337.
DOI: 10.1371/journal.pone.0235162.
Afrache H, Pontarotti P, Abi-Rached L, Olive D
Immunogenetics. 2017; 69(6):379-390.
PMID: 28382515
DOI: 10.1007/s00251-017-0980-z.
Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II.
Wistuba-Hamprecht K, Haehnel K, Janssen N, Demuth I, Pawelec G
Immun Ageing. 2015; 12:25.
PMID: 26640505
PMC: 4670504.
DOI: 10.1186/s12979-015-0052-x.
Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cells.
Lu J, Das M, Kanji S, Aggarwal R, Joseph M, Ray A
Biochim Biophys Acta. 2014; 1842(7):1071-9.
PMID: 24726882
PMC: 4082796.
DOI: 10.1016/j.bbadis.2014.04.003.
Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
Alejenef A, Pachnio A, Halawi M, Christmas S, Moss P, Khan N
Clin Exp Immunol. 2014; 176(3):418-28.
PMID: 24547915
PMC: 4008987.
DOI: 10.1111/cei.12297.
A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.
Thedrez A, Lavoue V, Dessarthe B, Daniel P, Henno S, Jaffre I
PLoS One. 2013; 8(5):e63322.
PMID: 23717410
PMC: 3662688.
DOI: 10.1371/journal.pone.0063322.
Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.
Marquez-Medina D, Salla-Fortuny J, Salud-Salvia A
Clin Transl Oncol. 2012; 14(12):891-5.
PMID: 23054752
DOI: 10.1007/s12094-012-0935-7.
EPCR: a stress trigger for γδ T cells.
Witherden D, Havran W
Nat Immunol. 2012; 13(9):812-4.
PMID: 22910386
DOI: 10.1038/ni.2398.
Prostaglandin I₂promotes the development of IL-17-producing γδ T cells that associate with the epithelium during allergic lung inflammation.
Jaffar Z, Ferrini M, Shaw P, FitzGerald G, Roberts K
J Immunol. 2011; 187(10):5380-91.
PMID: 21976777
PMC: 3208053.
DOI: 10.4049/jimmunol.1101261.
HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity.
Ciucci A, Gabriele I, Percario Z, Affabris E, Colizzi V, Mancino G
PLoS One. 2011; 6(8):e23766.
PMID: 21915243
PMC: 3161821.
DOI: 10.1371/journal.pone.0023766.
The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.
Tu W, Zheng J, Liu Y, Sia S, Liu M, Qin G
J Exp Med. 2011; 208(7):1511-22.
PMID: 21708931
PMC: 3135369.
DOI: 10.1084/jem.20110226.
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
Cui Q, Shibata H, Oda A, Amou H, Nakano A, Yata K
Int J Hematol. 2011; 94(1):63-70.
PMID: 21698356
DOI: 10.1007/s12185-011-0885-9.
γδ T cell receptor ligands and modes of antigen recognition.
Champagne E
Arch Immunol Ther Exp (Warsz). 2011; 59(2):117-37.
PMID: 21298486
PMC: 3317888.
DOI: 10.1007/s00005-011-0118-1.
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.
Braza M, Klein B, Fiol G, Rossi J
Haematologica. 2010; 96(3):400-7.
PMID: 21109686
PMC: 3046271.
DOI: 10.3324/haematol.2010.029520.
Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.
Urban E, Chapoval A, Pauza C
Clin Dev Immunol. 2010; 2010:732893.
PMID: 20396597
PMC: 2854522.
DOI: 10.1155/2010/732893.
Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.
Ali Z, Yan L, Plagman N, Reichenberg A, Hintz M, Jomaa H
J Immunol. 2009; 183(8):5407-17.
PMID: 19786533
PMC: 2863296.
DOI: 10.4049/jimmunol.0901760.
Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.
Wei H, Huang D, Lai X, Chen M, Zhong W, Wang R
J Immunol. 2008; 181(7):4798-806.
PMID: 18802083
PMC: 2743079.
DOI: 10.4049/jimmunol.181.7.4798.